Sleep Disorder Unit, Narcolepsy and Hypersomnia National Reference Center, Neurology Department, Gui-de-Chauliac Hospital, University Montpellier, France.
Institute for Neurosciences of Montpellier INM, University Montpellier, INSERM, Montpellier, France.
Sleep. 2021 May 14;44(5). doi: 10.1093/sleep/zsaa264.
Hypersomnolence, defined by excessive daytime sleepiness (EDS) or excessive quantity of sleep (EQS), has been associated with increased morbidity. The aim of this study was to determine the clinical and polysomnographic characteristics associated with EQS and EDS assessed objectively during extended polysomnography recording.
A total of 266 drug-free subjects (201 women; mean age: 26.5 years [16.08; 60.87]) underwent 32-h bed-rest polysomnography recording preceded by polysomnography and modified multiple sleep latency test (mMSLT). Participants were categorized according to their total sleep time (bed-rest TST ≥19 h, hypersomnia), objective EDS (mean sleep latency on MSLT ≤8 min), and self-reported EDS (Epworth sleepiness scale score >10) and EQS (≥9 h/24 h per week).
Subjects with hypersomnia were often younger, with normal sleep architecture, high nighttime sleep efficiency, and severe objective EDS. No association with sex, body mass index, Epworth sleepiness scale, EQS, and depressive symptoms was detected. Subjects with objective EDS had less EQS, higher sleep efficiency, and increased hypersomnia. Discrepancies were observed between objective and self-reported measures of sleep duration and EDS. Finally, 71 subjects were identified who had objective hypersomnia and/or EDS, no medical and psychiatric conditions and normal polysomnography parameters, and therefore met the stringent criteria of idiopathic hypersomnia, an orphan disorder.
Sleep duration and EDS should be quantified using self-reported and objective measures in a controlled procedure to differentiate long sleepers, patients with hypersomnia, and patients with idiopathic hypersomnia. This will help to better understand their biology, to identify specific biomarkers, and to assess related health outcomes.
日间过度嗜睡(EDS)或睡眠时间过多(EQS)定义的嗜睡症与发病率增加有关。本研究的目的是确定与 EQS 和 EDS 相关的临床和多导睡眠图特征,这些特征是在延长多导睡眠图记录期间通过客观评估得出的。
共有 266 名未服用药物的受试者(201 名女性;平均年龄:26.5 岁[16.08;60.87])接受了 32 小时卧床多导睡眠图记录,在此之前进行了多导睡眠图和改良多次睡眠潜伏期试验(mMSLT)。根据他们的总睡眠时间(卧床 TST≥19 小时,嗜睡症)、客观 EDS(MSLT 平均睡眠潜伏期≤8 分钟)、自我报告的 EDS(Epworth 嗜睡量表评分>10)和 EQS(每周≥9 小时/24 小时)进行分类。
嗜睡症患者通常较年轻,睡眠结构正常,夜间睡眠效率高,客观 EDS 严重。未发现与性别、体重指数、Epworth 嗜睡量表、EQS 和抑郁症状相关。客观 EDS 患者 EQS 较少,睡眠效率较高,嗜睡症增加。在睡眠持续时间和 EDS 的客观和自我报告测量之间观察到差异。最后,确定了 71 名受试者,他们具有客观的嗜睡症和/或 EDS、无医学和精神疾病以及正常的多导睡眠图参数,因此符合特发性嗜睡症的严格标准,这是一种罕见疾病。
应使用自我报告和客观措施来量化睡眠持续时间和 EDS,以区分长睡眠者、嗜睡症患者和特发性嗜睡症患者。这将有助于更好地了解他们的生物学,确定特定的生物标志物,并评估相关的健康结果。